Light Sciences Oncology Finishes Enrollment in Pivotal Clinical Trial
Light Sciences Oncology, a Bellevue, WA-based developer of cancer drugs, said it has completed enrollment of 200 patients with liver tumors in a clinical trial. The goal of the study is to see whether patients live longer after they get LitX. The company’s treatment is designed to use a light-emitting diode, threaded inside a tumor, to activate a drug to kill tumors within its wavelength. If the trial reaches it goal, the company plans to ask regulators in the U.S. and Europe for marketing approval in 2009.